IPSC
Century Therapeutics Inc
NASDAQ: IPSC · HEALTHCARE · BIOTECHNOLOGY
$2.20
+0.00% today
Updated 2026-04-29
Market cap
$396.78M
P/E ratio
—
P/S ratio
3.64x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$0 – $3
Volume
1.3M
Century Therapeutics Inc (IPSC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $104.30M | — | $-16.17M | $-41.27M | $-89.00M | $14.05M | $-88.35M | $-110.14M | $-103.88M |
| Capital expenditures | $29.39M | $11.12M | $2.46M | $9.82M | $44.97M | $30.60M | $13.74M | $154000.00 | $848000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $147000.00 | $876000.00 | $4.66M | $10.67M | $14.62M | $12.69M | $6.84M |
| Free cash flow | $74.90M | — | $-18.63M | $-51.09M | $-133.97M | $-16.55M | $-102.08M | $-110.29M | $-104.72M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $30.43M | $28.08M | — | — | — |